1cP-LSD 10 MCG Pellets – Microdose Product Description

Introduction

1cP-LSD, or 1-cyclopropionyl-lysergic acid diethylamide, is a semi-synthetic lysergamide and a structural analog of LSD distinguished by a cyclopropionyl functional group attached at the nitrogen-1 position of the lysergamide core. Distributed as 10 microgram pellets for precise microdosing applications, 1cP-LSD is used predominantly for laboratory research, analytical studies, and neuropharmacological exploration rather than for human consumption. Its molecular configuration is designed to facilitate detailed investigation of serotonergic psychedelics with potential differences from classic LSD.

Chemical Properties and Specifications

Structural and Molecular Characteristics

Chemical Formula: C24H29N3O2
Molecular Weight: 391.51 g/mol
CAS Number: 2767597-50-0
IUPAC Name: (6aR,9R)-N,N-Diethyl-7-methyl-4-(cyclopropanecarbonyl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Synonyms: 1cP-LSD, 1-Cyclopropionyl LSD, 1-cyclopropanoyl-d-lysergic acid diethylamide

Physical Properties and Purity Standards

Appearance: Typically formulated as small, precise microdose pellets for laboratory handling, the compound in pure form is a neat crystalline substance with a clear or slightly off-white color.
Purity: High-purity standards (generally ≥ 98%) are maintained for research-grade 1cP-LSD, ensuring minimal impurities for valid analytical studies.
Solubility: Soluble in organic solvents like acetonitrile, methanol, and ethanol, with limited aqueous solubility.
Storage Recommendations: Store in cool, dry, and dark conditions (ideally at -20°C) in tightly sealed containers to prevent degradation from heat, moisture, and light exposure.

Pharmacological Profile and Mechanism of Action

Proposed Mechanism of Action

1cP-LSD primarily acts as a potent agonist of the serotonin 5-HT2A receptor, believed to induce psychedelic effects via this receptor subtype integral to neural signalling pathways involved in perception and cognition. Animal models reflect psychedelic-like behavioral responses comparable to LSD and 1P-LSD. It is theorized to function as a prodrug, metabolically converting to LSD after administration, contributing to its pharmacodynamic effect spectrum.

Research Applications

1cP-LSD is utilized extensively in research involving receptor binding assays, structure-activity relationship studies, and the analysis of metabolic conversion pathways in psychedelic compounds. Its microdosed pellet form is ideal for precise dosing protocols in pharmacological experiments, facilitating fine-tuned investigations into serotonergic receptor modulation and neuropsychiatric pharmacology. Additionally, it supports stability and degradation studies and methodological validation for analytical chemistry.

Comparative Analysis with Related Compounds

Compare to Related Compounds

1cP-LSD differs chemically from LSD due to the cyclopropionyl substitution, which impacts metabolic pathways and potency characteristics. Compared to other LSD analogs like 1P-LSD and 1B-LSD, 1cP-LSD exhibits similar potency and receptor affinity but may have subtle variations in pharmacokinetics and experimental effects. The cyclopropionyl modification distinguishes it from other acyl-LSD derivatives.

Advantages for Research

The availability of 1cP-LSD in microdose pellets enables precise, reproducible dosing with minimal measurement error, advantageous for dose-response research and stability testing. Its distinct molecular profile permits structure-activity relationship studies while its suspected prodrug nature allows exploration of metabolic transformations relevant to LSD analogs.

Safety and Handling Guidelines

Laboratory Safety

Practice standard laboratory precautions with appropriate personal protective equipment (PPE) including gloves, lab coat, and eye protection. Handle pellets in a controlled environment, avoiding inhalation or ingestion of powders. Use fume hoods or well-ventilated areas to minimize exposure.

Disposal and Environmental Considerations

Dispose of 1cP-LSD waste according to hazardous chemical protocols established by regulatory authorities. Avoid environmental contamination by preventing release into waterways or waste streams.

Regulatory Status

1cP-LSD is typically classified as a research chemical and is subject to controlled substance regulations depending on jurisdiction. It is intended strictly for laboratory research and not approved for human use.

Frequently Asked Questions (FAQs)

1. What is 1cP-LSD used for in research?
   It is used to investigate psychedelic serotonin receptor interactions and metabolism in controlled studies.

2. How potent is 1cP-LSD compared to LSD?
   1cP-LSD has a potency profile approximately similar to 1P-LSD and somewhat less than LSD in some models.

3. What is the form of 1cP-LSD microdose pellets?
   Pellets are small, precisely dosed units, ideal for accurate microdosing in research.

4. Is 1cP-LSD considered a prodrug?
   Yes, it is presumed to metabolize in vivo to release LSD.

5. How should 1cP-LSD be handled safely?
   With appropriate PPE in ventilated laboratory conditions to prevent exposure.

Conclusion

1cP-LSD 10 MCG Pellets are a high-purity, microdosed form of a cyclopropionyl-substituted lysergamide analog to LSD. Tailored for laboratory research, these pellets enable precise dosing and reproducible experimentation in serotonergic pharmacology and psychedelic compound studies. Its unique chemical structure supports in-depth exploration of structure-activity relationships and metabolism under strict safety and regulatory compliance.